Supercharge Your Innovation With Domain-Expert AI Agents!

Process for preparing metered-dose inhaler for treating respiratory diseases

An inhalant and propellant technology, which is applied in the technical field of preparing quantitative spray inhalers for the treatment of respiratory diseases, can solve problems such as quality differences, technical difficulties, and poor patient acceptance of alcohol odor

Active Publication Date: 2017-05-24
INTECH BIOPHARM
View PDF24 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0020] 3). A large amount of ethanol: more than 10% ethanol can completely dissolve the drug, and other excipients can be added or not. The advantage is that the uniformity of administration is very good, and the disadvantage is that the drug stability may be poor and the patient's acceptance of alcohol odor is poor Wait
[0022] 5). Very low amount of ethanol: about 0.2-2% ethanol, such as the formulation of Valois company, the advantage is that the drug is in an insoluble suspension state, and the stability of the drug is optimal, but the disadvantage is that the uniformity of administration is poor, and other conferring agents are required. Formulation assistance, and may be more difficult in the process
Therefore, in the actual mass production of prescriptions in the pharmaceutical industry, even if the contents of the prescriptions are the same, there will still be quality differences due to the difference in the mixing order of ingredients and the way of filling equipment.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Process for preparing metered-dose inhaler for treating respiratory diseases
  • Process for preparing metered-dose inhaler for treating respiratory diseases
  • Process for preparing metered-dose inhaler for treating respiratory diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0097] 1. A preparation method for quantitative spray inhalation composition, comprising the following steps:

[0098] (a) 0.05%-10.0%w / w% alcohol is mixed with a surfactant to form a first mixed solution;

[0099] (b) dispersing the ethylene glycol synergist in the first mixed solution to form a second mixed solution;

[0100] (c) adding hydrofluoroalkane propellant (HFA) to the second mixed solution to form a third mixed solution;

[0101] (d) redispersing the corticosteroid in the third mixed solution; and

[0102] (e) Perform the filling step.

[0103] 2. A preparation method for quantitative spray inhalation composition, comprising the following steps:

[0104] (a) 0.05% to 10.0% w / w% alcohol is mixed with a surfactant to form a first mixed solution,

[0105] (b) dispersing the ethylene glycol synergist in the first mixed solution to form the second mixed solution,

[0106] (c) adding HFA to the second mixed solution to form a third mixed solution: and

[0107] (d) ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a prescription composition and a manufacturing process for preparing a quantitative spray inhaler, and the main components of the prescription composition can be ethylene glycol synergist, corticosteroid or a combination of the two. Its prescription is prepared into a uniform suspension dosage form, with hydrofluoroalkane (HFA) as propellant and a small amount of alcohol, polyethylene glycol (PEG) as suspending agent and particle size regulator.

Description

[0001] 【Technical field to which the invention belongs】 [0002] The invention provides a medicine-containing pressurized quantitative spray inhaler combination and a preparation method thereof. The pressurized quantitative spray inhaler is a medicine for treating respiratory related diseases such as asthma or chronic pulmonary obstruction. [0003] 【Background technique】 [0004] Pressurized Metered Dose Inhaler (pMDI) allows the inhaled drug to quickly display drug activity locally, and has lower systemic adverse reactions than oral drugs, and has been compared with dry powder inhaler (DryPowder Inhaler; DPI). It has become the most widely used mode of administration for the treatment of asthma (Asthma) or chronic obstructive pulmonary disease (Chronic Obstructive Pulmonary Disease, COPD). ), antiacetylcholine drugs (anticholinergic drugs), or a combination of the above ingredients. [0005] Since 3M developed the metered dose pressurized inhaler product with chlorofluorocar...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/12A61K45/06A61K31/58A61K31/573A61P11/06A61K31/137A61K31/167A61K31/4704
CPCA61K9/008A61P11/00A61P11/06A61P43/00
Inventor 吴维修赵彦钦
Owner INTECH BIOPHARM
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More